* Strategic alliance aims to foster collaboration with researchers working in various disease fields by using best-in-class PCR diagnostic technology * Companies will facilitate C-level cooperation, strengthening the partnership for the SG OneSystem™ business (Seegene’s technology-sharing business) Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR...
* Strategic collaboration to open a new chapter in the field of molecular diagnostics that aspires to 'a world free from all diseases and future pandemics' * Digitally enhance Seegene's automated diagnostic reagent development system with the integration of Microsoft Azure AI solutions * A declaration ceremony within 1H...
* Introduces NovaplexTM MPXV/OPXV plus Assay (RUO) that is designed to detect Clade I, which has higher transmission and mortality rates than Clade II * Adheres to the WHO issued target product profiles and provides accurate detection of viral strains * Offer healthcare professtional with a critical tool in their research on...
• The first tri-party executive roundtable was held in London to strengthen synergies for Seegene’s vision of creating ‘a world free from diseases’ • Preliminary results of product development automation and statistical analysis of syndromic test results powered with Microsoft’s AI technology were showcased • Global experts and scientists participated in...
Seegene, a leading PCR-based molecular diagnostic company, conducted an email interview with Dr. Mohd Azizuddin bin Mohd Yussof to gain insights into cervical cancer prevention in Malaysia. Cervical cancer is the ninth most common cancer among Malaysians and the third most common cancer among Malaysian women. At least 1,740...